MedPath

TEVA-LISINOPRIL (TYPE P)

TEVA-LISINOPRIL (TYPE P)

Discontinued
DIN Number

02285096

Drug Class

Human

Market Date

Oct 17, 2007

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02285096
AIG Number0121550002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09AA03 LISINOPRIL
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

LISINOPRILActive
Strength: 20 MG
Monograph: LISINOPRIL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.